Seamens Pharmaceuticals Pvt.Ltd.
About Seamens Pharmaceuticals Pvt.Ltd.
Data last updated:
Seamens Pharmaceuticals Pvt.Ltd. is a private limited company based in Kanpur, Uttar Pradesh, India. It operates in the diversified financial services segment of the financial services sector. It was incorporated on 28 February 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24231UP1995PTC017628.
The company has an authorised share capital of ₹55 Lakh and a paid-up capital of ₹46.25 Lakh. It is led by directors Dinesh Joshi and Kavita Joshi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 6 – Lakhanpur Avadhpuri Road, Kanpur, Uttar Pradesh, India – 208024.
As per the financials filed for FY 2025, the company reported a revenue of ₹32,180, a decline of 21% compared to the previous year. For the same year it recorded a net profit of ₹6,680 (net margin 20.8%) and EBITDA of ₹6,680 (EBITDA margin 20.8%). Revenue has declined at a compounded annual rate (CAGR) of 47% over three years and 2% over five years.
As per MCA filings, the company has open charges of ₹35 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Seamens Pharmaceuticals Pvt.Ltd.'s registered office is in Kanpur, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address6 – Lakhanpur Avadhpuri Road, Kanpur, Uttar Pradesh, India – 208024
- IndustryFinancial Services, Diversified Financial Services
To see the full contact details of Seamens Pharmaceuticals Pvt.Ltd., buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Seamens Pharmaceuticals Pvt.Ltd.
FY 2025 filings availableSeamens Pharmaceuticals Pvt.Ltd. reported revenue of ₹32,180 (down 21% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 21% fall in the latest year. EBITDA rose 169% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6,680 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6,680 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 20.8% | ||||
| Net Profit Margin | 20.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Seamens Pharmaceuticals Pvt.Ltd., buy the company report.
Board of directors of Seamens Pharmaceuticals Pvt.Ltd.
Seamens Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dinesh Joshi Also directs: Anprash Projects Private Limited, Dap Projects LLP, Envirad Projects Private Limited and 4 more | Director | 14 Nov 1998 | 27 Years 11 Months | Current |
| Kavita Joshi Also directs: Anprash Projects Private Limited | Director | 10 Dec 1999 | 26 Years 10 Months | Current |
Peer comparison
Seamens Pharmaceuticals Pvt.Ltd. is compared with the 10 companies closest to it by revenue in the BFSI industry (Other Financial Services, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Image Pharmaceuticals Private Limited | ₹32,514 (FY 2021) | -61.0% | Anand, Gujarat, India | |||
| Raj Jyoti Trading and Investment Private Limited | ₹32,438 (FY 2023) | -2.0% | Mumbai, Maharashtra, India | |||
| Jeevodayam Kuries Private Limited | ₹32,407 (FY 2025) | -87.0% | Thrissur, Kerala, India | |||
| Assam Surgical and Pharmaceuticals Pvt Ltd | ₹32,300 (FY 2016) | 10.0% | Guwahati, Assam, India | |||
| NH Time Investments Research Private Limited | ₹32,204 (FY 2024) | -88.0% | Thane, Maharashtra, India | |||
| Seamens Pharmaceuticals Pvt.Ltd.this company | ₹32,180 (FY 2025) | ₹6,680 | 20.8% | -21.0% | Kanpur, Uttar Pradesh, India | |
| Money-Shoppe Network Limited | ₹32,176 (FY 2019) | -15.0% | Chnnai, Tamil Nadu, India | |||
| Broadspectrum Pharmaceuticals Private Limited | ₹32,164 (FY 2018) | New Delhi, Delhi, India | ||||
| Sharp Way Mutual Benefit Nidhi Limited | ₹32,060 (FY 2021) | 19.0% | Navsari, Gujarat, India | |||
| Supershot Mercantile Private Limited | ₹32,024 (FY 2025) | -36.0% | Kolkata, West Bengal, India | |||
| Kalindi Vyapaar Private Limited | ₹32,000 (FY 2025) | 3.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Seamens Pharmaceuticals Pvt.Ltd., buy the company report.
Auditor
Seamens Pharmaceuticals Pvt.Ltd. is audited by P R S N & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P R S N & CO | FY 2021 | 009576C |
Shareholding
The shareholding of Seamens Pharmaceuticals Pvt.Ltd. is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Seamens Pharmaceuticals Pvt.Ltd., buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Dec 2014 | 10536054 | Union Bank of India | ₹35 Cr | Open |
To see the full charge records of Seamens Pharmaceuticals Pvt.Ltd., buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Seamens Pharmaceuticals Pvt.Ltd. are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Seamens Pharmaceuticals Pvt.Ltd.; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Seamens Pharmaceuticals has 1 associated company. This group structure data is as of FY 2021. The table lists each entity with its relationship and holding.
GST
No GST registration is on our record for Seamens Pharmaceuticals Pvt.Ltd.; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Seamens Pharmaceuticals Pvt.Ltd. has 2 board changes on record since 1998: 2 appointments. The latest: Kavita Joshi was appointed as Director on 10 Dec 1999.
Frequently asked questions
Seamens Pharmaceuticals is an active private limited company based in Kanpur, Uttar Pradesh, India. The company works in diversified financial services, within the financial services industry. It was incorporated on 28 February 1995 (31+ years old) and is registered under CIN U24231UP1995PTC017628.
Seamens Pharmaceuticals has 2 current directors:
- Dinesh Joshi - Director
- Kavita Joshi - Director
The latest financial statements of Seamens Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Seamens Pharmaceuticals is U24231UP1995PTC017628. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Seamens Pharmaceuticals was incorporated on 28 February 1995, making it 31+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Seamens Pharmaceuticals by revenue are Image Pharmaceuticals Private Limited, Raj Jyoti Trading and Investment Private Limited, Jeevodayam Kuries Private Limited, Assam Surgical and Pharmaceuticals Pvt Ltd, NH Time Investments Research Private Limited and 5 more, all in the BFSI industry (Other Financial Services, Pharmaceuticals).
Kavita Joshi was appointed as Director on 10 Dec 1999. Dinesh Joshi was appointed as Director on 14 Nov 1998.
The registered office of Seamens Pharmaceuticals is at 6 – Lakhanpur Avadhpuri Road, Kanpur, Uttar Pradesh, India – 208024.
Seamens Pharmaceuticals operates in the financial services industry, in the diversified financial services segment.
Seamens Pharmaceuticals has open charges of ₹35 Cr and no satisfied charges on record as per latest MCA filings.
The compliance status of Seamens Pharmaceuticals is compliant as of 19 September 2026. The company is actively filing with the Registrar of Companies.